These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 217561)
61. Smooth-muscle antibodies and antibodies to cytomegalovirus and Epstein-Barr virus in leukaemias and lymphomata. Andersen P; Molgaard J; Andersen I; Andersen HK Acta Pathol Microbiol Scand C; 1976 Apr; 84(2):86-92. PubMed ID: 178146 [TBL] [Abstract][Full Text] [Related]
62. Blood B and T lymphocytes and in vitro cellular immune reactivity in untreated human malignant lymphomas and other malignant tumors. Heier HE; Klepp R; Gundersen S; Godal T; Normann T Scand J Haematol; 1977 Feb; 18(2):137-48. PubMed ID: 138931 [TBL] [Abstract][Full Text] [Related]
63. Malignant lymphoma in four of five siblings. Nagel GA; Nagel-Studer E; Seiler W; Hofer HO Int J Cancer; 1978 Dec; 22(6):675-8. PubMed ID: 214406 [TBL] [Abstract][Full Text] [Related]
64. Immunologic considerations in the selection of nonhuman primate models for studies of Epstein--Barr virus-associated diseases in man. Levine PH; Wallen WC; Lai PK; Jerrells TR; Fuccillo DA Comp Immunol Microbiol Infect Dis; 1979; 2(2-3):243-56. PubMed ID: 228898 [No Abstract] [Full Text] [Related]
68. Lymphoproliferative effect of Epstein-Barr virus on normal human lymphocytes in cultures. Gerber P; Whang-Peng J; Monroe JH Bibl Haematol; 1970; (36):739-50. PubMed ID: 4376394 [No Abstract] [Full Text] [Related]
70. [Epstein-Barr-virus-antibodies and lymphocytotoxic serum-antibodies in patients with sarcoidosis]. Becker FW; Gallmeier WM; Hertenstein C; Kalden JR Klin Wochenschr; 1972 Oct; 50(19):927-8. PubMed ID: 4343096 [No Abstract] [Full Text] [Related]
71. [Radiation effect and its recovery on cellular immunity in patients with non-Hodgkin lymphoma (author's transl)]. Kubota N; Asakura K; Ohtake E; Ono Y; Matsui K Nihon Igaku Hoshasen Gakkai Zasshi; 1979 Jun; 39(6):645-52. PubMed ID: 482081 [No Abstract] [Full Text] [Related]
72. Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas. Gazdar AF; Carney DN; Bunn PA; Russell EK; Jaffe ES; Schechter GP; Guccion JG Blood; 1980 Mar; 55(3):409-17. PubMed ID: 6244013 [No Abstract] [Full Text] [Related]
73. The effect of indomethacin treatment on lymphocyte PHA reactivity in healthy controls and patients with lymphoma and sarcoidosis. Underhill G; Valdimarsson H Br J Haematol; 1985 Jul; 60(3):423-8. PubMed ID: 4015987 [TBL] [Abstract][Full Text] [Related]
74. Lymphocyte stimulation in patients with lymphoma cutis. Mekori T; Robinson E; Haim S Oncology; 1974; 30(4):273-7. PubMed ID: 4459741 [TBL] [Abstract][Full Text] [Related]
75. Stimulation of autologous blood lymphocytes by malignant lymphoma cells and homogenates. Ludgate ME; Gough J Br J Cancer; 1976 Dec; 34(6):619-25. PubMed ID: 1008989 [TBL] [Abstract][Full Text] [Related]
76. An immunological basis for inhibition of transformation of human lymphocytes by EB virus. Moss DJ; Scott W; Pope JH Nature; 1977 Aug; 268(5622):735-6. PubMed ID: 197426 [No Abstract] [Full Text] [Related]
77. Fluorescent probes for rapid tests of cellular immunoreactivity. Nairn RC; Rolland JM Pathology; 1984 Jan; 16(1):1-3. PubMed ID: 6232492 [No Abstract] [Full Text] [Related]
78. Evaluation of lymphocyte reactivity studies in patients with thermal burns. Daniels JC; Sakai H; Cobb EK; Lewis SR; Larson DL; Ritzmann SE J Trauma; 1971 Jul; 11(7):595-601. PubMed ID: 5555683 [No Abstract] [Full Text] [Related]